Crossmark

Is the risk of brain metastasis and prognosis different in HER2-low breast cancer?

Crossref DOI link: https://doi.org/10.1007/s12094-025-04106-6

Published Online: 2025-11-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Culha, Yaşar https://orcid.org/0000-0002-0317-7552
Ünlü, Beyza https://orcid.org/0000-0002-8178-0277
Davarcı, Sena Ece https://orcid.org/0000-0003-1142-9411
Güzel, Halil Göksel https://orcid.org/0000-0001-8310-1752
Demir, Hacer https://orcid.org/0000-0003-1235-9363
Öztürk, Banu https://orcid.org/0000-0003-0290-8787
Baykara, Meltem https://orcid.org/0000-0003-3291-8134
License Information

Text and Data Mining valid from 2025-11-12

Version of Record valid from 2025-11-12
More Information

Article History

Received: 16 August 2025

Accepted: 20 October 2025

First Online: 12 November 2025

Declarations

:

: The authors declare no conflicts of interest.

: All authors have approved the manuscript and consented to publication.